Nuvectis Pharma sets up $200 million at-the-market equity program with Jefferies

Reuters2026/08/21 20:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Nuvectis Pharma set up an at-the-market equity offering program to sell common stock from time to time through Jefferies.
Program to be conducted under a new Form S-3 shelf registration statement covering USD 200 million of securities.
Jefferies to earn up to 3% of gross proceeds on shares sold under the sales agreement.
Prior at-the-market program tied to a February 13, 2026 prospectus supplement was terminated on July 20, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nuvectis Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-099712), on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Nuvectis Pharma sets up $200 million at-the-market equity program with Jefferies

You may also like

Crypto prices